Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a potent class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, enhancing https://johsocial.com/story10398834/emerging-glucagon-like-peptide-1-receptor-agonists-a-comprehensive-review